CTLA4 and colorectal carcinoma: Other authors have reported that the flavonoid epigallocatechin is able to inhibit tumor cell growth via the PI3K pathway and can be used as a chemotherapeutic [42], a chemopreventive agent [43], or as combinatorial therapy with anti-CTLA4 [44] against CRC.